Thursday, January 29, 2009

SAFETY OF CHROMIUM

Most of the concerns regarding the long-term safety of chromium supplementation arise from results of several cell culture studies using supraphysiological doses that suggested that chromium, particularly in the form of CrP, may increase DNA damage.

However, there is currently no evidence that chromium increases DNA damage in vivo. There have also been isolated reports of serious adverse events, including kidney failure, associated with CrP treatment, but the relationship of chromium to these events is not clear.

Recent reviews of the safety of CrP by the Institute of Medicine (84) and by Berner et al. have concluded that CrP is safe. Results from controlled clinical trials have shown that treatment with chromium at doses up to 1,000 µg/day and for periods as long as 64 months does not result in any toxic effects.

ADDITIONAL:

Figure Above - Effects of chromium supplementation on insulin sensitivity in overweight subjects with a family history of diabetes treated for 8 months with 1,000 µg/day CrP (64). Data are means ± SD. *P < 0.05, **P < 0.005 versus baseline.
Conclusion : Data show that insulin sensitivity was increased for the group patient which is supplied with chromium.

Therapeutic Footwear For Diabetes Care

Therapeutic footwear has been used for decades as one of many strategies to prevent reulceration in patients with diabetes and foot risk factors. The findings of several studies reporting statistically significant protective effects from therapeutic footwear may have been influenced by several design issues.

When considering the appropriateness of therapeutic footwear recommendations for moderate-risk patients, clinicians and patients should jointly explore individual strategies to decrease events that lead to foot ulcers

People with diabetes are at increased risk for lower-extremity amputations due to peripheral neuropathy and peripheral vascular disease.

Therapeutic footwear (custom-molded shoes, depth-inlay shoes with inserts, or custom-molded insoles) can prevent or relieve some diabetic foot problems but can be expensive and is often not covered by insurance.

Foot ulcerations and amputation rates are decreased among patients receiving intensive foot care including the use of therapeutic shoes.

Medicare pays for therapeutic footwear when you meet certain criteria and fill out the proper forms. This benefit covers custom-molded shoes, extra-depth shoes, inserts, and some shoe modifications.

Your physician must certify that you are in a plan of diabetes care, have evidence of foot disease, and need therapeutic footwear. A podiatrist writes the prescription, and a podiatrist or pedorthist provides the shoes.

You must buy the footwear from a qualified supplier and file the forms. You can get the forms from the prescription shoe stores, Medicare, or a podiatrist, or your provider may help you get them. Usually you have to pay for the shoes, and Medicare will reimburse up to 80% of the reasonable charge within limits.

Ask about the charge and how much Medicare will pay when you order the shoes. Although government programs can be time consuming, prescription footwear can be an important part of preventing foot problems.

Source : American Diabetes Association

YOU CAN GET GTF SUPPLEMENT THROUGH THIS FOLLOWING AGENT: